Feverfew (Tanacetum parthenium)
What Is Feverfew?
Botanists and formularies know Feverfew as Tanacetum parthenium, a plant of the Asteraceae family, native to Europe and western Asia. The material in circulation is leaf, aerial parts — leafy growth taken above ground. The common name Feverfew and the botanical name Tanacetum parthenium refer to the same material, and labels may use either — a detail that matters when related species in the same genus are not interchangeable. In the hand it reads as bitter, pungent, citrus-camphor — a practical marker of freshness and correct identification.
Historically, Feverfew was learned by hand: which stands to harvest, how to dry the leaf, aerial parts without spoiling it, and how much to use. Those observations were recorded generations before its compounds were named. Beyond its practical use it carries cultural associations — medieval 'feather-few' — associated with lightness and protection and planted around homes for protection in European folklore.
Today most searches for Feverfew come from people reading about fever, headache, energy and joint health, or checking how it sits alongside a medication they already take. The use most often documented in the literature is may reduce migraine frequency and severity, followed by anti-inflammatory (parthenolide inhibits NF-κB).
How Does Feverfew Work?
Feverfew is not a single active substance. Its chemistry is a mixture, and the fractions that researchers isolate most often are Parthenolide. Parthenolide is the fraction most often standardised in extracts, associated in the literature with anti-migraine sesquiterpene lactone.
The older understanding of Feverfew is procedural rather than molecular — which part to take, in what season, and in what medium — and modern constituent work has largely been an attempt to explain why those procedures were chosen.
Published research is limited, leaning on small trials, laboratory work and animal models, and this profile cites 3 sources. Reported findings centre on cochrane review (2015) found inconclusive evidence for migraine prophylaxis. Where research exists, it examines may reduce migraine frequency and severity, anti-inflammatory (parthenolide inhibits NF-κB) and traditional use in fever and arthritis. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
What makes Feverfew distinct is the combination rather than any one molecule: the same compound classes appear in other botanicals, but their ratio here — and the leaf, aerial parts they are drawn from — is what the traditional and research literature both describe.
Because these constituents are processed by the same pathways that handle many medicines, Feverfew is documented as interacting with anticoagulants / antiplatelets, nsaids and iron supplements. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Feverfew can differ substantially; this is why reference entries specify leaf, aerial parts and, where they exist, standardisation markers.